Cannabis in Japan

Cannabis in Japan

Currently, the medical cannabis market is very limited in Japan, but the illegal cannabis market is growing along with the legal CBD market. In 1948, Japan’s Cannabis Control Act prohibited cannabis use, restricting its cultivation to purposes such as fibre, seeds and research, under directives from the post-war GHQ administration. This Act remained largely unchanged until 2023, when the Ministry of Health, Labour and Welfare (MHLW), following expert committee discussions in 2021-2022, initiated...

Euromonitor International's Cannabis in Japan market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2029 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.